Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma

Jiangfeng Hu; Chenlin Song; Bensong Duan; Xiaoyan Zhang; Dongliang Li; Liang Zhu; Hengjun Gao

doi:10.18632/oncotarget.25888

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma

PDF | How to cite

Oncotarget. 2018; 9:31311-31311. https://doi.org/10.18632/oncotarget.25888

Metrics: PDF 1480 views | ?

Jiangfeng Hu^1,*, Chenlin Song^2,*, Bensong Duan^1,*, Xiaoyan Zhang³, Dongliang Li⁴, Liang Zhu⁵ and Hengjun Gao^6,7

¹ Department of Gastroenterology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China
² Division of Molecular Biology of the Cell II, German Cancer Research Center, DKFZ-ZMBH Alliance, Heidelberg, Germany
³ Shanghai Engineering Center for Molecular Medicine, National Engineering Center for Biochip at Shanghai, Shanghai, China
⁴ Department of Hepatobiliary Medicine, Fuzhou General Hospital of Nanjing Command, PLA, Fuzhou, China
⁵ Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China
⁶ National Engineering Center for Biochip at Shanghai, Shanghai, China
⁷ Department of Gastroenterology, Institute of Digestive Diseases, Tongji University School of Medicine, Shanghai, China
^* These authors contributed equally to this work

Published: July 27, 2018

This article has been corrected: The correct city name is given below:

⁷ Department of Gastroenterology, Institute of Digestive Diseases, Tongji University School of Medicine, Shanghai, China

Original article: Oncotarget. 2017; 8:97835-97850. DOI: https://doi.org/10.18632/oncotarget.18279.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25888

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma